Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P6
Near historical low
vs 5Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -16.23% |
| Q3 2025 | -20.20% |
| Q2 2025 | -11.30% |
| Q1 2025 | -14.56% |
| Q4 2024 | -4.78% |
| Q3 2024 | 3.56% |
| Q2 2024 | -7.35% |
| Q1 2024 | -11.97% |
| Q4 2023 | -5.35% |
| Q3 2023 | 22.81% |
| Q2 2023 | -10.84% |
| Q1 2023 | 0.99% |
| Q4 2022 | -7.81% |
| Q3 2022 | -2.15% |
| Q2 2022 | -8.95% |
| Q1 2022 | -9.55% |
| Q4 2021 | -28.82% |
| Q3 2021 | 3.39% |
| Q2 2021 | 17.09% |
| Q1 2021 | 28.52% |
| Q4 2020 | 37.33% |
| Q3 2020 | 27.13% |
| Q2 2020 | 38.29% |
| Q1 2020 | -1.42% |
| Q4 2019 | 32.41% |
| Q3 2019 | -0.21% |
| Q2 2019 | 87.39% |
| Q1 2019 | 26.65% |
| Q4 2018 | 45.86% |
| Q3 2018 | 10.95% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |